Mednet Logo
CommunityRadiation Oncology

How do you manage favorable intermediate risk prostate cancer patients that have a PIRADS 5 lesion that was most-likely missed in the template biopsy?

For example, a patient that received an MRI after biopsy that demonstrates a PIRADS 5 lesion in anterior TZ which likely was not sampled on biopsy. Would you request directed biopsy of the PIRADS 5 lesion prior to commencing RT+/-ADT?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Urology · Stanford University, School of Medicine
Answered on

Yes, I'd suggest a repeat biopsy before treatment. In the case of radiation +/- ADT, a repeat biopsy may impact the dosimetry of radiation, whether or not ADT is used, and how long ADT is used as part of treatment.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UC San Diego
Answered on

I definitely recommend a targeted biopsy of an anterior PI-RADS 5 lesion. The only exception that comes to mind is systematic biopsy already showed grade group 4-5 cancer in the posterior gland (i.e., a new cancer won’t change management).

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Columbia University Medical Center
Answered on

I agree with Dr. @Dr. First Last's answer. I'd also wait before sending a Decipher in this case, as the Decipher should, ideally, be performed on the tissue with the highest Grade Group score.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

MR guided repeat biopsy

Join for free or sign in to see the full answer